10-Q/A [Amend] – Quarterly report [Sections 13 or 15(d)]

(Filing, Q2, Mannkind, 2016, AUG 10, 2016, View Source [SID:1234514491])

Use the contact form at the top or bottom of this page to book a free demo to 1stOncology™, an all inclusive cancer drug development intelligence platform from BioSeeker. The platform provides value in oncology for you in areas such as:

Target scouting
Indication selection & expansion
Combinatorial drug settings
Drug repositioning
First in class analysis
Compound cross over analysis
Competitive analysis
Pathway analysis

and much more...